top of page
Search


April 21-28, 2025 Lipid Nanoparticle (LNP) News Brief Summary
StatNano/Grand View Research: A new market report forecasts the global lipid nanoparticle market to reach $1.54 billion by 2030, growing at a CAGR of 13.64%, driven by increased demand for innovative drug delivery solutions.
SyVento BioTech: SyVento BioTech participates in the World Vaccine Congress in Washington, D.C., showcasing their expertise in lipid-based nanocarriers and LNP technology for pharmaceutical products including RNA-based drug products.
Arbor Biotechno
1 day ago


Lipid Nanoparticle (LNP) News Summary (April 14–21, 2025)
Arbor Biotechnologies: Unveiled FDA approval of an IND filing for their LNP-mediated treatment for primary hyperoxaluria type 1.
Rothwell Figg (Dan Shores): Led a workshop on intellectual property challenges for LNP-based therapies at the LNP Summit.
NOF CORPORATION: Presented biodegradable LNPs with tunable immunogenicity for vaccine and gene therapy applications.
Serina Therapeutics: Introduced immune-silent POZ-lipid technology as a PEG alternative for LNPs at the
Apr 21


Lipid Nanoparticle (LNP) Drug Delivery Advances, April 7-14, 2025
University of Pennsylvania: Developed nitro-oleic acid-modified LNPs for safer plasmid DNA delivery, enabling long-term gene expression in mice.
ACS Biochemistry Study: Introduced click chemistry LNPs for targeted mRNA delivery to metabolically labeled cancer cells.
Marama Labs: Launched CloudSpec, a tool for rapid lipid nanoparticle analysis, reducing lab times from hours to seconds.
Global Market Report: Projected lipid nanoparticle market growth to US$2.39 billion by 20
Apr 14


High-Throughput Screening Applications for Lipid Nanoparticle Development and Optimization
High-Throughput Screening Applications for Lipid Nanoparticle Development and Optimization
Apr 9


Lipid Nanoparticle Drug Delivery Advances April 1-7, 2025
Sanofi: Published research in Nanoscale on optimizing PEGylated lipids for enhanced mRNA delivery efficacy and stability.
University of
Apr 7


Lipid Nanoparticle Drug Delivery Advances, March 23-30, 2025
Serina Therapeutics: Presented preclinical data on non-immunogenic POZ-lipid technology at the ACS Spring 2025 Meeting. Genevant Sciences an
Mar 31


Technical Review: Developing mRNA Lipid Nanoparticle Vaccine Effective for Cryptococcosis in a Murine Model
This paper falls within the fields of medical mycology, immunology, and vaccinology, specifically addressing the emerging application of mRN
Mar 28


Lipid Nanoparticle (LNP) Drug Delivery Advances, March 17-24, 2025
Frontiers in Nanotechnology: Published research article on RNA-lipid nanoparticle therapeutics for women's health, focusing on gynecological
Mar 24


Lipid Nanoparticle (LNP) Drug Delivery Advances, March 10-17, 2025
News Summary
Nature: Published research on fabrication of mRNA encapsulated lipid nanoparticles using SMART-MaGIC technologies.
Clinical P
Mar 18


Structural Characterization of mRNA Lipid Nanoparticles in the Presence of Intrinsic Drug-free Lipid Nanoparticles
Authors: Xiaoxia Chen, Yongfeng Ye, Mengrong Li, Taisen Zuo, Zhenhua Xie, Yubin Ke, He Cheng, Liang Hong, and Zhuo Liu Abstract Lipid...
Sep 28, 2024


The 22nd International Nanomedicine and Drug Delivery Symposium NanoDDS 2024
The 22nd International Nanomedicine and Drug Delivery Symposium NanoDDS 2024
Sep 13, 2024


Proteolysis targeting chimera extracellular vesicles for therapeutic developmenttreating triple negative breast cancer
Authors: Nina Erwin, Umasankar De, Yufeng Xiao, Lei Wang, Chandra Maharjan, Xiaoshu Pan, Nikee Awasthee, Guangrong Zheng, Daiqing Liao,...
Aug 26, 2024
bottom of page